A Randomized Trial of Medically-Inoperable Stage 1 Non-small Cell Lung Cancer Patients Comparing Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy
A multi-centre randomized controlled open-label trial in medically inoperable patients with
biopsy-proven early stage non-small cell lung cancer (NSCLC). Eligible and consenting
patients will be randomly allocated to receive stereotactic body radiation therapy (SBRT) or
conventional radiation therapy (CRT) in a 2:1 ratio. Radiation Therapy will be administered as soon as
possible following randomization and subjects will be followed for 5 years
post-randomization for cancer recurrence, toxicity and survival. The primary outcome is
local control (LC). The trial will be conducted at 16-20 clinical centres throughout Canada.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society